Coverage
-
June 20, 2019
Roughly three weeks after suing the supposed masterminds of his ouster from biotech company Retrophin Inc., notorious pharmaceutical executive Martin Shkreli has settled the suit as well as a years-old fight with his former company.
1 other articles on this case.
View all »